161 related articles for article (PubMed ID: 34162126)
1. A risk signature with inflammatory and immune cells infiltration predicts survival and efficiency of chemotherapy in gastric cancer.
Li S; Sun S; Sun H; Ma P; Zhang J; Cao Y; Liu C; Zhang X; Wang W; Li Z; Ma Y; Xue Y; Zhao Y
Int Immunopharmacol; 2021 Jul; 96():107589. PubMed ID: 34162126
[TBL] [Abstract][Full Text] [Related]
2. Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer.
Jiang Y; Xie J; Huang W; Chen H; Xi S; Han Z; Huang L; Lin T; Zhao LY; Hu YF; Yu J; Cai SR; Li T; Li G
Cancer Immunol Res; 2019 Dec; 7(12):2065-2073. PubMed ID: 31615816
[TBL] [Abstract][Full Text] [Related]
3. An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer.
Yan H; Chen Y; Yang Z; Li Z; Che X; Xiao J; Liu Y; Qu X
Front Immunol; 2020; 11():621623. PubMed ID: 33613554
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the infiltration of CD163
Huang X; Pan Y; Ma J; Kang Z; Xu X; Zhu Y; Chen J; Zhang W; Chang W; Zhu J
Cancer Med; 2018 May; 7(5):1731-1741. PubMed ID: 29573574
[TBL] [Abstract][Full Text] [Related]
5. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
6. A Risk Signature With Inflammatory and T Immune Cells Infiltration in Colorectal Cancer Predicting Distant Metastases and Efficiency of Chemotherapy.
Hu X; Li YQ; Ma XJ; Zhang L; Cai SJ; Peng JJ
Front Oncol; 2019; 9():704. PubMed ID: 31456937
[TBL] [Abstract][Full Text] [Related]
7. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
8. Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients.
Koh J; Ock CY; Kim JW; Nam SK; Kwak Y; Yun S; Ahn SH; Park DJ; Kim HH; Kim WH; Lee HS
Oncotarget; 2017 Apr; 8(16):26356-26367. PubMed ID: 28412752
[TBL] [Abstract][Full Text] [Related]
9. Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer.
Lu J; Xu Y; Wu Y; Huang XY; Xie JW; Wang JB; Lin JX; Li P; Zheng CH; Huang AM; Huang CM
BMC Cancer; 2019 Sep; 19(1):920. PubMed ID: 31521128
[TBL] [Abstract][Full Text] [Related]
10. Tumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer.
Carus A; Ladekarl M; Hager H; Nedergaard BS; Donskov F
Br J Cancer; 2013 May; 108(10):2116-22. PubMed ID: 23591202
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil infiltration is a favorable prognostic factor in early stages of colon cancer.
Wikberg ML; Ling A; Li X; Öberg Å; Edin S; Palmqvist R
Hum Pathol; 2017 Oct; 68():193-202. PubMed ID: 28882699
[TBL] [Abstract][Full Text] [Related]
12. CD66b
Cong X; Zhang Y; Zhu Z; Li S; Yin X; Zhai Z; Zhang Y; Xue Y
Cancer Med; 2020 Apr; 9(8):2761-2773. PubMed ID: 32096331
[TBL] [Abstract][Full Text] [Related]
13. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
[No Abstract] [Full Text] [Related]
14. Intratumoral Foxp3
Fei Y; Cao Y; Gu Y; Fang H; Chen Y; Wang J; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Li R; Zhang H; Zhang W
Cancer Immunol Immunother; 2022 Jan; 71(1):1-11. PubMed ID: 33978826
[TBL] [Abstract][Full Text] [Related]
15. The Interplay Between Neutrophils and CD8
Governa V; Trella E; Mele V; Tornillo L; Amicarella F; Cremonesi E; Muraro MG; Xu H; Droeser R; Däster SR; Bolli M; Rosso R; Oertli D; Eppenberger-Castori S; Terracciano LM; Iezzi G; Spagnoli GC
Clin Cancer Res; 2017 Jul; 23(14):3847-3858. PubMed ID: 28108544
[No Abstract] [Full Text] [Related]
16. Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation.
Kim EK; Yoon SO; Jung WY; Lee H; Kang Y; Jang YJ; Hong SW; Choi SH; Yang WI
Gastric Cancer; 2017 May; 20(3):438-447. PubMed ID: 27318497
[TBL] [Abstract][Full Text] [Related]
17. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer.
Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485
[TBL] [Abstract][Full Text] [Related]
18. Impact of the immune cell population in peripheral blood on response and survival in patients receiving neoadjuvant chemotherapy for advanced gastric cancer.
He Q; Li G; Ji X; Ma L; Wang X; Li Y; Fan C
Tumour Biol; 2017 May; 39(5):1010428317697571. PubMed ID: 28475005
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating Neutrophils is Prognostic and Predictive for Postoperative Adjuvant Chemotherapy Benefit in Patients With Gastric Cancer.
Zhang H; Liu H; Shen Z; Lin C; Wang X; Qin J; Qin X; Xu J; Sun Y
Ann Surg; 2018 Feb; 267(2):311-318. PubMed ID: 27763900
[TBL] [Abstract][Full Text] [Related]
20. Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy.
Dieci MV; Tsvetkova V; Griguolo G; Miglietta F; Tasca G; Giorgi CA; Cumerlato E; Massa D; Lo Mele M; Orvieto E; Guarneri V; Conte P
Eur J Cancer; 2020 Sep; 136():7-15. PubMed ID: 32622323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
